Yahoo Web Search

Search results

1. • 

     Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?

     Motley Fool via Yahoo Finance· 6 hours ago

     Though it won't be competing with those two heavyweights directly until it finishes the clinical...

2. • Quest Partners LLC Takes $313,000 Position in Eli Lilly and Company (NYSE:LLY)

     ETF DAILY NEWS· 8 hours ago

     Quest Partners LLC purchased a new stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the fourth quarter, Holdings Channel reports. The fund purchased ...

3. • Lilly(Eli) & Co (LLY): Significant Improvements, Worth Being Considered – Stocks Register

     Stocks Register· 1 day ago

     Lilly(Eli) & Co (NYSE:LLY) concluded the trading at $807.43 on Friday, May 24 a fall of -0.13% from its closing price on previous day. Taking a look at stock we notice that ...

4. • 

     Got $500? 3 Pharma Stocks to Buy and Hold Forever

     Motley Fool via Yahoo Finance· 2 hours ago

     And there's not much better in a pharma stock than a defensible core business with multiple growth initiatives that are about to crest beyond the cusp of...

5. • Eli Lilly and Company (NYSE:LLY) Stock Price Up 1.2%

     ETF DAILY NEWS· 1 day ago

     Eli Lilly and Company (NYSE:LLY – Get Free Report)’s share price rose 1.2% during mid-day trading on Thursday . The company traded as high as $815.00 and last traded at $812.18 ...

6. • Lilly (LLY) Hits Record High on Crohn's Disease Study Data

     Zacks· 4 days ago

     Free Report) rose nearly 3% on Tuesday after it reported detailed one-year results from the phase III VIVID-1 study, which evaluated its IL-23p19 antibody mirikizumab in adults with Crohn’s ...

7. • Eli Lilly stock maintains price target with Jefferies' buy rating By Investing.com

     Investing.com· 6 days ago

     On Monday, Jefferies maintained a confident stance on Eli Lilly (NYSE:LLY) shares, reiterating a Buy rating and a price target of $915.00. The affirmation comes after competitor ...

8. • 

     Eli Lilly to invest $5.3 billion to expand production of Zepbound and Mounjaro By Investing.com

     Investing.com· 2 days ago

     Eli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand...

9. • 

     .../Diabetes Drug Tirzepatide Why Is Eli Lilly Stock Trading Higher On Tuesday? - Eli Lilly and Co...

     Benzinga· 5 days ago

     On Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes...

10. • 

      Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic...

      Benzinga· 2 days ago

      Friday, Eli Lilly And Company LLY announced it has more than doubled its investment in its Lebanon,...